LICANDRO, SIMONETTA ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 652
EU - Europa 447
AS - Asia 111
SA - Sud America 10
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.223
Nazione #
US - Stati Uniti d'America 647
DE - Germania 157
IT - Italia 133
IE - Irlanda 56
SE - Svezia 52
HK - Hong Kong 40
CN - Cina 33
IN - India 17
FI - Finlandia 16
GB - Regno Unito 9
FR - Francia 8
AR - Argentina 6
CA - Canada 5
UA - Ucraina 5
DK - Danimarca 4
KR - Corea 4
TR - Turchia 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
EC - Ecuador 2
LU - Lussemburgo 2
NL - Olanda 2
PH - Filippine 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
SG - Singapore 2
TW - Taiwan 2
AT - Austria 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
MY - Malesia 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 1.223
Città #
Frankfurt am Main 138
Chandler 104
Fairfield 77
Ann Arbor 76
Dublin 52
Ashburn 44
Hong Kong 40
Milan 35
Wilmington 33
Woodbridge 33
New York 31
Princeton 28
Cambridge 23
Houston 23
Rome 17
Seattle 17
Lawrence 14
Helsinki 13
Shanghai 13
Hangzhou 8
San Diego 8
Cagliari 6
San Francisco 5
Albignasego 4
Altamura 4
Buenos Aires 4
Cinisello Balsamo 4
Naples 4
Pune 4
Salò 4
Andover 3
Boston 3
Brooklyn 3
Dearborn 3
Fondi 3
Hamburg 3
Nanjing 3
Norwalk 3
Rennes 3
San Nicola la Strada 3
Scottsdale 3
Ahmedabad 2
Ancona 2
Ariccia 2
Baltimore 2
Bari 2
Bergamo 2
Bergisch Gladbach 2
Bonn 2
Changsha 2
Chicago 2
City of Westminster 2
Créteil 2
Dubai 2
Duezce 2
Durham 2
Fishers 2
Florence 2
Giessen 2
Lecce 2
Mumbai 2
North Reading 2
Padova 2
Palo del Colle 2
Paris 2
Parma 2
Quito 2
Rive d'Arcano 2
Riyadh 2
San Mateo 2
Silver Spring 2
Somma Lombardo 2
Sorocaba 2
Stockholm 2
Strassen 2
Suwon 2
Taipei 2
Toronto 2
Trieste 2
Turin 2
Windsor 2
't Loo 1
Abano Terme 1
Albany 1
Alexandria 1
Beauharnois 1
Boardman 1
Caldwell 1
Cape Town 1
Casirate d'Adda 1
Chennai 1
Chiswick 1
Den Haag 1
Edmonton 1
Fort Lee 1
Guangzhou 1
Halethorpe 1
Hebei 1
Hyderabad 1
Islington 1
Totale 998
Nome #
Evaluation of the anti-fibrotic effect of Givinostat, a pan-HDAC inhibitor, in different Duchenne Muscular Dystrophy murine models. 223
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 189
The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene 148
The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts 92
Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts 79
3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors 72
Application of 3D Mass Spectrometry Imaging to TKIs 64
Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia 61
A nanostructured matrices assessment to study drug distribution in solid tumor tissues by mass spectrometry imaging 56
Mode of action of trabectedin in myxoid liposarcomas 54
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging 53
Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin 53
PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel Carriers 48
HPLC-MS/MS method to measure trabectedin in tumors: Preliminary PK study in a mesothelioma xenograft model 48
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma 48
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 12
Totale 1.300
Categoria #
all - tutte 4.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 0 3
2019/202036 4 3 3 0 1 2 2 1 8 5 7 0
2020/2021283 45 38 28 24 10 10 50 27 16 12 18 5
2021/2022132 11 11 15 2 1 5 14 14 8 5 19 27
2022/2023471 30 101 67 27 32 68 2 58 55 3 18 10
2023/2024337 25 14 44 16 60 48 35 25 35 19 16 0
Totale 1.300